Exciting News: Restoration of Federal Funding for the Utah Clinical and Translational Science Institute!

On March 29, 2025, the University of Utah got good news: funding was restored for the Utah Center and Translational Science Institute (CTSI). This support from the National Center for Advancing Translational Sciences (NCATS) is crucial for the center’s mission to bridge the gap between research and practical healthcare solutions.

Recently, NCATS revised their Notice of Award, fully reinstating the funding that had been unexpectedly cut earlier that month. This funding, totaling $38 million over seven years, is vital for the institute as it approaches the third year of the grant.

Rachel Hess, MD, MS, who co-directs Utah CTSI, expressed gratitude toward various supporters including university leadership, legislative members, and the local community. “Their support has been instrumental for Utah CTSI and our efforts to enhance healthcare,” she noted.

Utah CTSI plays a key role in advancing research into real-world medical applications, especially for rural areas. In 2024 alone, the institute managed a biorepository with 557,000 samples and facilitated over 5,000 research projects, impacting nearly 7,000 clinical trial participants. They are part of a national network of over 60 programs dedicated to accelerating research into effective patient care.

As the institute continues its vital work over the next five years, it will closely collaborate with NCATS. This partnership will ensure alignment with federal funding goals, enhancing the impact of their ongoing projects.

In healthcare research, the journey from the lab to actual treatment can be long and complex. Programs like Utah CTSI are essential in shortening that path, making breakthroughs more accessible to those who need them most.

For more information about the Utah Center and Translational Science Institute, visit their official website.

Check out this related article: Stay Prepared: Essential Severe Weather Forecast for Monday, March 31st